Prothena Corp Public PRTA
NASDAQ PRTA
$8.61 -0.16 (-1.88%)
As of: Sep 30, 2026 · 10:22 AM EDT

Prothena Corp Public (PRTA) Total Non-Current Liabilities (2012 - 2026)

Updated

Prothena Corp Public (PRTA) posted Total Non-Current Liabilities of $4.03 million for Q2 2026, down 41.8% from $6.93 million a year earlier and down 15.4% from the prior quarter.

Analysis

Prothena Corp Public (PRTA) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Prothena Corp Public's Total Non-Current Liabilities came in at $5.49 million, down 53.0% from FY2024.

  • Annual Total Non-Current Liabilities has declined for seven consecutive years, with a five-year compound annual growth rate of -46.3% (FY2020 to FY2025).
  • In prior years, Prothena Corp Public's Total Non-Current Liabilities was $11.68 million in FY2024 (-85.0%), $78.13 million in FY2023 (-9.0%), $85.85 million in FY2022 (-21.9%) and $109.87 million in FY2021 (-10.8%).
  • The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q1 2016.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last 16 quarters, with an average decline of 64.2% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2022, with growth of 7.3%; the weakest was Q1 2025, with a decline of 88.1%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $4.76 million (Q1 2026), $5.49 million (Q4 2025) and $6.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Prothena Corp Public 451.21 Mn -804.86 Mn - 4.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.03 Mn
Mar 31, 2026 4.76 Mn
Dec 31, 2025 5.49 Mn
Sep 30, 2025 6.20 Mn
Jun 30, 2025 6.93 Mn
Mar 31, 2025 9.20 Mn
Dec 31, 2024 11.68 Mn
Sep 30, 2024 14.47 Mn
Jun 30, 2024 16.90 Mn
Mar 31, 2024 77.53 Mn
Dec 31, 2023 78.13 Mn
Sep 30, 2023 76.32 Mn
Jun 30, 2023 67.41 Mn
Mar 31, 2023 85.29 Mn
Dec 31, 2022 85.85 Mn
Sep 30, 2022 99.19 Mn
Jun 30, 2022 102.18 Mn
Mar 31, 2022 106.03 Mn
Dec 31, 2021 109.87 Mn
Sep 30, 2021 113.03 Mn
API Access

Prothena Corp Public Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PRTA&period=max&api_key=YOUR_API_KEY